Faron Pharmaceuticals Oy
FPHAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $7 | $7 | $7 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $3 | $5 |
| Total Curr. Assets | $11 | $9 | $10 | $12 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $1 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $2 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13 | $10 | $11 | $13 |
| Liabilities | – | – | – | – |
| Payables | $5 | $9 | $5 | $2 |
| Short-Term Debt | $4 | $4 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $3 |
| Other Curr. Liab. | $1 | $2 | $3 | $4 |
| Total Curr. Liab. | $10 | $15 | $10 | $7 |
| LT Debt | $8 | $9 | $11 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | -$0 |
| Other NC Liab. | $4 | $1 | $1 | $0 |
| Total NC Liab. | $12 | $10 | $12 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $22 | $25 | $23 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | -$197 | -$172 | -$144 | -$116 |
| AOCI | $0 | $0 | $0 | $116 |
| Other Equity | $185 | $154 | $129 | -$0 |
| Total Equity | -$10 | -$15 | -$11 | $3 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13 | $10 | $11 | $13 |
| Net Debt | $3 | $6 | $6 | -$3 |